-
Mashup Score: 3Insights into the early use of oral semaglutide in routine clinical practice: The IGNITE study - 3 year(s) ago
Oral semaglutide is the first oral glucagon-like peptide-1 receptor agonist (GLP-1 RA) for type 2 diabetes mellitus, demonstrating significant benefits in glycaemic control and weight reduction versu…
Source: Diabetes, Obesity and MetabolismCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 0Prescribing trends and clinical characteristics of patients starting antiobesity drugs in the United States - 3 year(s) ago
Aim To assess the trends in the prescribing of antiobesity medications and the characteristics of patients recently initiating antiobesity drugs. Materials and Methods We conducted a population‐ba…
Source: Diabetes, Obesity and MetabolismCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 2Applying REWIND cardiovascular disease criteria to SUSTAIN 6 and PIONEER 6: An exploratory analysis of cardiovascular outcomes with semaglutide - 3 year(s) ago
In the REWIND trial, dulaglutide reduced cardiovascular (CV) risk versus placebo in patients with type 2 diabetes in both the “established CV disease” (CVD) and “CV risk factor” subgroups. The SUSTAI…
Source: Diabetes, Obesity and MetabolismCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0
Aim To better understand the healthcare burden of people with type 2 diabetes (T2D) and estimated glomerular filtration rate (eGFR) < 90 mL/min/1.73 m2 in Ontario, Canada. Materials and Methods We...
Source: Diabetes, Obesity and MetabolismCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 2
Click on the title to browse this issue
Source: Diabetes, Obesity and MetabolismCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 10
Aims To understand the relationship between glycated haemoglobin (HbA1c) and brain health, across the entire glycaemic spectrum. We hypothesised that individuals with increasingly higher HbA1c would…
Source: Diabetes, Obesity and MetabolismCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 6
Aim To undertake a cost‐effectiveness analysis of dapagliflozin in treating high‐risk patients with type 2 diabetes mellitus (T2DM), using both directly observed events in the DECLARE‐TIMI 58 trial …
Source: Diabetes, Obesity and MetabolismCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 6Interaction of diabetes genetic risk and successful lifestyle modification in the Diabetes Prevention Program. - 3 year(s) ago
Aims Intensive lifestyle intervention (ILS) targeting health behaviors is efficacious for diabetes mellitus prevention, but there is heterogeneity in the effect of ILS. We tested whether diabetes ge…
Source: Diabetes, Obesity and MetabolismCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 0
Aim To conduct a meta‐analysis to determine the effects of continuous positive airway pressure (CPAP) treatment on glycaemic control and insulin resistance in patients with type 2 diabetes and obstr…
Source: Diabetes, Obesity and MetabolismCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 1Pioglitazone and bariatric surgery are the most effective treatments for non‐alcoholic steato‐hepatitis: a hierarchical network meta‐analysis - 3 year(s) ago
Aims To compare different treatments for Non‐Alcoholic Steato‐Hepatitis (NASH) and to determine an effectiveness hierarchy. Materials‐and‐Methods This is a systematic review and Bayesian Network M…
Source: Diabetes, Obesity and MetabolismCategories: Healthcare Professionals, Latest HeadlinesTweet
Insights into the early use of oral semaglutide in routine clinical practice: The IGNITE study https://t.co/8GPjjCdr92